NINDS Neuroscience Funding Announcements

Parkinson's Disease Neuroprotection Clinical Trial: Clinical Centers
Funding Contact: NINDS Funding Coordinator
Funding Categories: Neurodegeneration

Brief Description:
The Neurodegeneration and Clinical Trial Groups of the National Institute of Neurological Disorders and Stroke (NINDS) request applications for clinical centers to collaborate in the performance of a large, double-blind randomized trial of two or more potential neuroprotective agents in patients early in the course of Parkinson’s disease. Applications for coordinating and statistical centers were requested in a separate solicitation (http://grants.nih.gov/grants/guide/rfa-files/RFA-NS-01-012.html). The trial was called for in the NIH Parkinson Research Agenda (http://www.ninds.nih.gov/about_ninds/nihparkinsons_agenda.htm). The neuroprotectants to be tested in the trial have not yet been chosen and will be selected by an NINDS-appointed Oversight Committee from among those proposed by the applicants who respond to this Request for Applications (RFA) as well as from those suggested by others, including NINDS grantees, pharmaceutical companies, patients, and patient advocates.

NIH Guide: RFA-NS-02-010
Release Date: 2001-07-02
Expiration Date: 2001-11-16